ZA201502073B - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number
ZA201502073B
ZA201502073B ZA2015/02073A ZA201502073A ZA201502073B ZA 201502073 B ZA201502073 B ZA 201502073B ZA 2015/02073 A ZA2015/02073 A ZA 2015/02073A ZA 201502073 A ZA201502073 A ZA 201502073A ZA 201502073 B ZA201502073 B ZA 201502073B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
ZA2015/02073A
Inventor
Preeti Raut
Geena Malhotra
Original Assignee
Cipla Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cipla Ltd filed Critical Cipla Ltd
Publication of ZA201502073B publication Critical patent/ZA201502073B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
ZA2015/02073A 2014-03-28 2015-03-26 Pharmaceutical composition ZA201502073B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1141MU2014 2014-03-28

Publications (1)

Publication Number Publication Date
ZA201502073B true ZA201502073B (en) 2016-03-30

Family

ID=54194023

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2015/02073A ZA201502073B (en) 2014-03-28 2015-03-26 Pharmaceutical composition

Country Status (2)

Country Link
WO (1) WO2015145157A1 (en)
ZA (1) ZA201502073B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019053500A1 (en) 2018-04-17 2019-03-21 Alvogen Malta Operations (Row) Ltd Pharmaceutical composition of solid dosage form containing pazopanib and process for its preparation
KR20220003975A (en) * 2020-07-02 2022-01-11 주식회사 삼양홀딩스 A tablet comprising Pazopanib as an active ingredient and a method of preparation thereof
WO2022040446A1 (en) * 2020-08-19 2022-02-24 Nanocopoeia, Llc Amorphous pazopanib particles and pharmaceutical compositions thereof
EP4255436A1 (en) * 2020-12-07 2023-10-11 HHT Foundation International, Inc. Method of treating hereditary hemorrhagic telangiectasia using pazopanib

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2616500C2 (en) * 2011-10-31 2017-04-17 Новартис Аг Pazopanib composition
PL2802314T3 (en) * 2012-01-13 2021-06-14 Xspray Microparticles Ab A method for producing stable, amorphous hybrid nanoparticles comprising at least one protein kinase inhibitor and at least one polymeric stabilizing and matrix- forming component.

Also Published As

Publication number Publication date
WO2015145157A1 (en) 2015-10-01

Similar Documents

Publication Publication Date Title
HK1225655A1 (en) Pharmaceutical compositions comprising azd9291
GB201618482D0 (en) Pharmaceutical compositions
GB201419257D0 (en) Pharmaceutical compositions
GB201409471D0 (en) Pharmaceutical composition
IL249553A0 (en) Pharmaceutical compositions
SG11201605366QA (en) Pharmaceutical composition containing pyridylaminoacetic acidcompound
GB201409485D0 (en) Pharmaceutical composition
GB201409488D0 (en) Pharmaceutical composition
ZA201702086B (en) Long acting pharmaceutical compositions
GB201521462D0 (en) Pharmaceutical composition
GB201515310D0 (en) Pharmaceutical composition
ZA201502073B (en) Pharmaceutical composition
IL250817A0 (en) Pharmaceutical compositions
ZA201508726B (en) Pharmaceutical composition
GB201520862D0 (en) Pharmaceutical composition
PT3200772T (en) Pharmaceutical compositions comprising alpelisib
SI3236952T1 (en) Pharmaceutical tablet composition
PL3089740T3 (en) Pharmaceutical composition
SG11201608123VA (en) Pharmaceutical composition for external use
SG10201504332VA (en) Pharmaceutical Composition
SG11201608124XA (en) Pharmaceutical composition for external use
GB201521456D0 (en) Pharmaceutical composition
GB201516183D0 (en) Novel pharmaceutical composition
SG11201608122PA (en) Pharmaceutical composition for external use
SG2014014872A (en) Pharmaceutical compositions